ASP
  • COVID
    • INPATIENT >
      • CONSIDERATIONS & LABS
      • PAXLOVID
      • REMDESIVIR
      • OLUMIANT
      • ACTEMRA
      • STEROIDS
      • VTE
    • OUTPATIENT
  • Education
    • Bugs & Tips
    • Agents & Spectra
  • Guidelines
    • By Infection Type
    • Surgical Prophylaxis >
      • By Procedure
      • Dosing Guide
  • Formulary
  • Antibiogram
    • 2023 Inpatient
    • 2023 Outpatient
    • 2022 Inpatient
    • 2022 Outpatient
    • 2021 Inpatient
    • 2021 Outpatient
    • 2020 Inpatient
    • 2019 Inpatient
    • 2019 Outpatient
  • About
    • ASP Program
    • Stats & Data >
      • Recommendations
      • Pharmacy Data
      • MDR ORGANISMS
      • DDD/DOT
    • Contact

Streptococcus pyogenes (group a strep)

LAB WORK
  • Gram +, beta-hemolytic (complete hemolysis)

TREATMENT
  • Penicillins are drug of choice since all strains are susceptible, cultures may not show sensitivity result for this reason
  • Second line:
    • Cefazolin (all cephalosporins)
    • Vancomycin
    • Fluoroquinolones
  • Agents with variable activity (avoid due to resistance concerns):
    • Tetracyclines
    • Clindamycin
      • Group A toxic shock syndrome: clindamycin has been added to penicillin-based treatment, it may inactivate toxins
    • Bactrim
​
CLINICAL NOTES
  • Common human pathogen (normal flora in up to 15% of people)
  • Toxin-producing strains may be involved in severe, rapidly-worsening infections (e.g., necrotizing fasciitis, myositis, and toxic shock syndrome)
  • Post-infection sequelae
    • Acute rheumatic fever
      • Group A strep has M proteins as a virulence factor; anti-M protein antibodies' cross-reaction with heart muscle is the underlying mechanism for rheumatic fever
    • Acute glomerulonephritis
      • Immune-mediated, may occur 1-3 weeks post infection
  • COVID
    • INPATIENT >
      • CONSIDERATIONS & LABS
      • PAXLOVID
      • REMDESIVIR
      • OLUMIANT
      • ACTEMRA
      • STEROIDS
      • VTE
    • OUTPATIENT
  • Education
    • Bugs & Tips
    • Agents & Spectra
  • Guidelines
    • By Infection Type
    • Surgical Prophylaxis >
      • By Procedure
      • Dosing Guide
  • Formulary
  • Antibiogram
    • 2023 Inpatient
    • 2023 Outpatient
    • 2022 Inpatient
    • 2022 Outpatient
    • 2021 Inpatient
    • 2021 Outpatient
    • 2020 Inpatient
    • 2019 Inpatient
    • 2019 Outpatient
  • About
    • ASP Program
    • Stats & Data >
      • Recommendations
      • Pharmacy Data
      • MDR ORGANISMS
      • DDD/DOT
    • Contact